Press Release FeedGet the RSS feed
Menu

GlobeNewswire

Nasdaq Verafin and Stablecore Partner to Unify Fiat and Digital Asset Financial Crime Detection

GlobeNewswire

NEW YORK, Sept. 15, 2026 -- Nasdaq Verafin and Stablecore today announced a partnership that unifies digital asset and traditional banking data to help financial institutions detect financial crime across fiat and digital asset activity. Stablecore provides the infrastructure banks and credit unions use to offer stablecoins, tokenized deposits, and other digital asset services inside their existing systems. The partnership brings digital asset transaction activity from Stablecore directly into the Nasdaq Verafin platform, giving banks and credit unions a consolidated view of financial crime risk exposure as they expand into digital asset services. With a more complete view of financial crime risk exposure, this partnership helps financial institutions meet customer demand for digital asset offerings while addressing evolving compliance requirements.

  1. FinanceOpenWorld (NASDAQ: OPNW) Signs Definitive Merger Agreement to Acquire BlocksightOpenWorld (NASDAQ: OPNW) Signs Definitive Merger Agreement to Acquire Blocksight as the Agentic Foundation for Its Up to $1 Billion Tokenized Solar and AI Computing Program with Meridian and Up to $130 Million IP-Backed Transaction with BeyondAI. Blocksight's AI agents are expected to handle deal structuring, asset verification, investor onboarding and daily reporting across more than $1.1 billion in recently announced tokenized financing programs on the OpenWorld Enterprise platform
  2. One Day to Go: Four Core Highlights of the 2026 iCAUR International User SummitCompanies: CheryA core focus of the experience is how the vehicles maintain stability and handle changing terrain.
  3. FinanceZentalis Pharmaceuticals Announces First Overall Survival Data for Azenosertib from DENALI Part 1b Published in ESMO Congress 2026 AbstractZentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment approach for ovarian cancer, today announced that overall survival (OS) data from an interim analysis of the DENALI Part 1b study (GOG-3066) have been published in the abstract for the upcoming rapid oral presentation at the European Society for Medical Oncology (ESMO) Congress 2026.
  4. HealthcareEikon Therapeutics Announces Availability of Seven Abstracts for Presentation at the European Society for Medical Oncology CongressPresentations to cover updates across Eikon’s clinical pipeline including:
  5. Cambria Gold Mines Intersects 98.56 g/t Gold over 8.2 Metres at the Silver Coin Deposit, Premier Gold ProjectCambria Gold Mines Inc. (TSXV: CAMB; OTCQX: CAMVF) (“Cambria” or the “Company”) is pleased to announce new assay results from the ongoing infill drilling program at the Premier Mining Complex (the “Premier Gold Project” or “PGP”), located near Stewart in northwestern British Columbia. Results from four diamond drillholes totalling 657 metres are reported herein. Highlight intervals include:
  6. FinanceDisc Medicine IncDisc Medicine to Host Corporate Webcast to Discuss Topline Results from the APOLLO Phase 3 Trial of Bitopertin in Erythropoietic Protoporphyria (EPP)Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced it will host a corporate webcast to discuss topline results from the APOLLO Phase 3 trial of bitopertin in EPP. The webcast will be held on Monday, October 19, 2026 at 8:00 a.m. ET.